Top Ten most popular articles on Pharmafile.com this week
pharmafile | October 16, 2020 | News story | Medical Communications | COVID, herd immunity, top ten, top ten articles
The top ten news stories this week focus on herd immunity, as the Director of the World Health Organization has warned against pursuing a strategy of herd immunity to fight national COVID-19 outbreaks, while a group of 80 researchers have lent their signatures to an open letter published in the The Lancet warning in particular against the resurgence of the pursuit of herd immunity as a credible strategy to combat national outbreaks of the novel coronavirus.
In other news, Eli Lilly has stopped enrolling volunteers in clinical trials of its antibody treatment for the novel coronavirus over safety concerns, and an American man has caught coronavirus for the second time, with the second infection being far more dangerous than the first.
1. Eli Lilly COVID-19 antibody therapy trial paused over safety concerns
Eli Lilly has stopped enrolling volunteers in clinical trials of its antibody treatment for the novel coronavirus over safety concerns.
2. Head of WHO says herd immunity strategies for COVID-19 are ‘unethical’
Tedros Adhanom Ghebreyesus, Director of the World Health Organization, has warned against pursuing a strategy of herd immunity to fight national COVID-19 outbreaks.
3. Sun Pharma issues recall of its generic diabetes drug in US market
Sun Pharma is recalling 747 bottles of its generic diabetes drug Riomet ER in the US.
4. 80 researchers argue COVID-19 herd immunity strategy is a “dangerous fallacy” in open letter
A group of 80 researchers have lent their signatures to an open letter published in the The Lancet under the title ‘Scientific consensus on the COVID-19 pandemic: We need to act now’, warning in particular against the resurgence of the pursuit of herd immunity as a credible strategy to combat national outbreaks of the novel coronavirus.
5. University of Glasgow research details promising precision medicine approach in pancreatic cancer
Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients with the therapies most likely to prove effective in repairing DNA damage in their tumour cells.
6. Man in US contracts COVID-19 for the second time with worse symptoms
An American man has caught coronavirus for the second time, with the second infection being far more dangerous than the first.
7. Pharmaceutical industry donating more to Democrats than Republicans in the lead up to 2020 election
The long-term trend of the pharmaceutical industry largely donating to the US Republican Party has been reversed in the lead up to the 2020 election.
8. Scottish Medicines Consortium approves Revlimid for two groups of blood cancer patients
The Scottish Medicines Consortium (SMC) has accepted Revlimid (lenalidomide) for routine use on NHS Scotland for patients with multiple myeloma and follicular lymphoma.
9. British man suffers from permanent hearing damage after contracting COVID-19
A 45-year-old man in the UK has been left with permanent hearing damage after being infected with the novel coronavirus, it has emerged.
10. J&J halts COVID-19 vaccine study following unidentified participant illness
Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following the illness of one of the participants.
Conor Kavanagh
Related Content
More than 13,000 women report period changes after COVID vaccine
The number of women who have reported changes to their period to the MHRA after …
Pharmafile.com’s top 10 news stories of the week
In the last week, a number of new developments have made the news; for COVID-19, …
Pharmafile.com’s weekly COVID-19 news round-up
The past week has continued to see positive COVID-19 news; CytoDyn’s treatment for patients with …
